CD4 augments the response of a T cell to agonist but not to antagonist ligands

Immunity

Volumn 7, Issue 3, 1997, Pages 379-385

  Hampl, Johannes ^a   Chien, Yueh Hsiu ^a   Davis, Mark M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; HYBRIDOMA; MOLECULAR STABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0030863079     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80359-3     Document Type: Article

References (36)

1. Alam, S.M., Travers, P.J., Wung, J.L., Nasholds, W., Redpath, S., Jameson, S.C., and Gascoigne, N.B. (1996). T-cell-receptor affinity and thymocyte positive selection. Nature 381, 616-620.
2. Brady, R.L., and Barclay, A.N. (1996). The structure of CD4. Curr. Top. Microbiol. Immunol. 205, 1-18.
3. Cammarota, G., Scheirle, A., Takacs, B., Doran, D.M., Knorr, R., Bannwarth, W., Guardiola, J., and Sinigaglia, F. (1992). Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules. Nature 356, 799-801.
4. Corr, M., Slanetz, A., Boyd, L., Jelonek, M., Khilko, S., al-Ramadi, B., Kim, Y., Maher, S., Bothwell, A., and Margulies, D. (1994). T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity. Science 265, 946-949.
5. De Magistris, M.T., Alexander, J., Coggeshall, M., Altaman, A., Gaeta, F.C., Grey, H.M., and Sette, A. (1992). Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor. Cell 68, 625-634.
6. Dialynas, D.P., Quan, Z.S., Wall, K.A., Pierres, A., Quintans, J., Loken, M.R., Pierres, M., and Fitch, F.W. (1983). Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131, 2445-2451.
7. Garcia, K., Scott, C., Brunmark, A., Carbone, F., Peterson, P., Wilson, I., and Teyton, L. (1996). CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 384, 577-581.
8. Hedrick, S.M., Matis, L.A., Hecht, T.T., Samelson, L.E., Longo, D.L., Heber-Katz, E., and Schwartz, R.H. (1982). The fine specificity of antigen and la determinant recognition by T cell hybridoma clones specific for pigeon cytochrome c. Cell 30, 141-152.
9. Jameson, S.C., and Bevan, M.J. (1995). T cell receptor antagonists and partial agonists. Immunity 2, 1-11.
10. Jameson, S.C., Hogquist, K.A., and Bevan, M.J. (1994). Positive selection of thymocytes. Annu. Rev. Immunol. 13, 93-126.
11. Janeway, C.A., Jr. (1992). The T cell receptor as a multicomponent signaling machine: CD4/CD8 coreceptors and CD45 in T cell activation. Annu. Rev. Immunol. 10, 645-674.
12. Kersh, G.J., and Allen, P.M. (1996). Essential flexibility in the T-cell recognition of antigen. Nature 380, 495-498.
13. Konig, R., Huang, L.-Y., and Germain, R.N. (1992). MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature 356, 796-798.
14. Konig, R., Shen, X., and Germain, R.N. (1995). Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activation. J. Exp. Med. 182, 779-787.
15. Konig, R., Fleury, S., and Germain, R.N. (1996). The structural basis of CD4-MHC class II interactions: coreceptor contributions to T cell receptor antigen recognition and oligomerization-dependent signal transduction. Curr. Top. Microbiol. Immunol. 205, 19-46.
16. Lyons, D.S., Lieberman, S.A., Hampl, J., Boniface, J.J., Chien, Y., Berg, L.J., and Davis, M.M. (1996). A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. Immunity 5, 53-61.
17. Madrenas, J., and Germain, R.N. (1996). Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation. Semin. Immunol. 8, 83-101.
18. Madrenas, J., Wange, R.L., Wang, J.L., Isakov, N., Samelson, L.E., and Germain, R.N. (1995). Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 267, 515-518.
19. Madrenas, J., Chau, L.A., Smith, J., Bluestone, J.A., and Germain, R.N. (1997). The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 185, 219-229.
20. Mannie, M.D., Rosser, J.M., and White, G.A. (1995). Autologous rat myelin basic protein is a partial agonist that is converted into a full antagonist upon blockade of CD4. Evidence for the integration of efficacious and nonefficacious signals during T cell antigen recognition. J. Immunol. 154, 2642-2654.
21. Marrack, P., Endres, R., Shimonkevitz, R., Zlotnik, A., Dialynas, D., Fitch, F.W., and Kappler, J. (1983). The major histocompatibility complex-restricted antigen receptor on T-cells. II. Role of the L3T4 product. J. Exp. Med. 158, 1077-1091.
22. Matsui, K., Boniface, J., Reay, P., Schild, H., Fazekas de St. Groth, B., and Davis, M. (1991). Low affinity interaction of peptide-MHC complexes with T cell receptors. Science 254, 1788-1791.
23. Matsui, K., Boniface, J.J., Steffner, P., Reay, P.A., and Davis, M.M. (1994). Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness. Proc. Natl. Acad. Sci. USA 91, 12862-12866.
24. McKeithan, T.W. (1995). Kinetic proofreading in T-cell receptor signal transduction. Proc. Natl. Acad. Sci. USA 92, 5042-5044.
25. + thymocytes by T-cell receptor peptide antagonists. Proc. Natl. Acad. Sci. USA 91, 4057-4061.
26. Portoles, P., Rojo, J., Golby, A., Bonneville, M., Gromkowski, S., Greenbaum, L., Janeway, C.A., Jr., Murphy, D.B., and Bottomly, K. (1989). Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation. J. Immunol. 142, 4169-4175.
27. Rabinowitz, J.D., Beeson, C., Lyons, D.S., Davis, M.M., and McConnell, H.M. (1996). Kinetic discrimination in T-cell activation. Proc. Natl. Acad. Sci. USA 93, 1401-1405.
28. Reay, P.A., Kantor, R.M., and Davis, M.M. (1994). Use of global amino acid replacements to define the requirements for MHC binding and T cell recognition of moth cytochrome c (93-103). J. Immunol. 152, 3946-3957.
29. Reich, Z., Boniface, J.J., Lyons, D.S., Borochov, N., Wachtel, E.J., and Davis, M.M. (1997). Ligand-specific oligomerization of T-cell receptor molecules. Nature 387, 617-620.
30. Schwartz, R.H. (1985). T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. Annu. Rev. Immunol. 3, 237-261.
31. Sette, A., Alexander, J., Ruppert, J., Snoke, K., Franco, A., Ishioka, G., and Grey, H.M. (1994). Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu. Rev. Immunol. 12, 413-431.
32. Sloan-Lancaster, J., Shaw, A.S., Rothbard, J.B., and Allen, P.M. (1994). Partial T cell signaling: altered phospho-ζ and lack of Zap70 recruitment in APL-induced T cell anergy. Cell 79, 913-922.
33. Spain, L.M., Jorgensen, J.L., Davis, M.M., and Berg, L.J. (1994). A peptide antigen antagonist prevents the differentiation of T cell receptor transgenic thymocytes. J. Immunol. 152, 1709-1717.
34. Vidal, K., Hsu, B.L., Williams, C.B., and Allen, P.M. (1996). Endogenous altered peptide ligands can affect peripheral T cell responses. J. Exp. Med. 183, 1311-1321.
35. Weber, S., Traunecker, A., Oliveri, F., Gerhard, W., and Karjalainen, K. (1992). Specific low-affinity recognition of major histocompatibility complex plus peptide by soluble T-cell receptor. Nature 356, 793-796.
36. Windhagen, A., Scholz, C., Hollsberg, P., Fukaura, H., Sette, A., and Hafler, D.A. (1995). Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2, 373-380.